531173 Stock Overview
Syschem (India) Limited manufactures and sells APIs, intermediates, bulk drugs, and specialty chemicals in India.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Syschem (India) Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹63.32 |
52 Week High | ₹73.90 |
52 Week Low | ₹36.32 |
Beta | -0.55 |
1 Month Change | 7.93% |
3 Month Change | -3.03% |
1 Year Change | 52.58% |
3 Year Change | 807.16% |
5 Year Change | 632.87% |
Change since IPO | 358.84% |
Recent News & Updates
Recent updates
Shareholder Returns
531173 | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | 0.7% | -0.5% | 1.4% |
1Y | 52.6% | 55.3% | 46.1% |
Return vs Industry: 531173 underperformed the Indian Pharmaceuticals industry which returned 55.3% over the past year.
Return vs Market: 531173 exceeded the Indian Market which returned 46.1% over the past year.
Price Volatility
531173 volatility | |
---|---|
531173 Average Weekly Movement | 4.2% |
Pharmaceuticals Industry Average Movement | 6.0% |
Market Average Movement | 6.8% |
10% most volatile stocks in IN Market | 10.1% |
10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 531173 has not had significant price volatility in the past 3 months.
Volatility Over Time: 531173's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1993 | 82 | Ranjan Jain | www.syschem.in |
Syschem (India) Limited manufactures and sells APIs, intermediates, bulk drugs, and specialty chemicals in India. The company’s APIs/intermediates include amoxycillin trihydrate, ampicillin trihydrate, cloxacillin sodium, dicloxacillin sodium, flucloxacillin sodium, cephalexin, cefixime, and cefadroxil. It also engages in the distillation of specialty solvents, such as DMF, acetonitrile, ethyl acetate, and THF; and contract manufacturing business.
Syschem (India) Limited Fundamentals Summary
531173 fundamental statistics | |
---|---|
Market cap | ₹2.52b |
Earnings (TTM) | ₹34.14m |
Revenue (TTM) | ₹2.02b |
73.9x
P/E Ratio1.2x
P/S RatioIs 531173 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
531173 income statement (TTM) | |
---|---|
Revenue | ₹2.02b |
Cost of Revenue | ₹1.64b |
Gross Profit | ₹385.33m |
Other Expenses | ₹351.18m |
Earnings | ₹34.14m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.86 |
Gross Margin | 19.04% |
Net Profit Margin | 1.69% |
Debt/Equity Ratio | 6.0% |
How did 531173 perform over the long term?
See historical performance and comparison